我国中药产品出口大洋洲的贸易现状及发展战略  

Current Situation and Development Strategy of Export of Chinese Medicine Products to Oceania

作　　者：李亚楠 刘国秀 王燕平[2] 翟华强[1] 王永炎[2] LI Yanan;LIU Guoxiu;WANG Yanping;ZHAI Huaqiang;WANG Yongyan(Standardization Research Center of Chinese Materia Medica Dispensing,Beijing University of Chinese Medicine,Beijing 102488,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China)

机构地区：[1]北京中医药大学中药调剂标准化研究中心,北京102488 [2]中国中医科学院中医临床基础医学研究所,北京100700

出　　处：《世界中医药》2022年第18期2674-2680,共7页World Chinese Medicine

基　　金：国家重点研发计划项目(2019YFC1712000)——中医临床药学服务与调剂教育国际标准研制(2019YFC1712002)。

摘　　要：随着“一带一路”重大倡议的实施,中医药的国际影响力逐渐增加,中药的国际化进程加快。中医药在澳大利亚具有深厚的发展基础,且澳大利亚与欧盟20多个国家生产质量管理规范(GMP)相互认证,因此我国中药产品在澳大利亚上市对于促进中药国际化具有现实意义。本文以“大洋洲”“新西兰中药”“澳大利亚药品”“澳大利亚中药”“中药出口”等为主题词,检索国家知识基础设施数据库(CNKI)和中国学术期刊数据库(CSPD)等数据库和相关研究报告,分析我国中药产品在大洋洲的准入政策和市场结构,梳理中药出口大洋洲的优势与局限,针对性地提出策略与建议,旨在为我国中药产品出口大洋洲的路径提供依据和参考。With the proposal of the Belt and Road Initiative,the international influence of Chinese medicine has gradually increased and the internationalization of Chinese medicine is gradually accelerating.Australia is the first overseas country to legislate for Chinese medicine,which has laid a solid foundation for the development of Chinese medicine in the country.Australia and more than 20 member countries of European Union have mutual good manufacturing practice(GMP)certification.Therefore,exporting Chinese medicine products to Australia has practical significance for the internationalization of Chinese medicine.By searching databases such as CNKI and WanFang data for the research reports with the keywords of Oceania,New Zealand Chinese Medicine,Australian Medicine,Australian Chinese Medicine,and Chinese Medicine Product Export,we analyzed the access policy and market structure of Chinese medicine products in Oceania,summarized the advantages and limitations,and finally proposed targeted measures and suggestions for the export of Chinese medicine products to Oceania.

关 键 词：中药贸易 大洋洲 澳大利亚 治疗产品管理-生产质量管理规范认证 中药国际化 质量标准 问题分析 发展战略 

分 类 号：R28[医药卫生—中药学] F741[医药卫生—中医学]